Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation

被引:2
|
作者
Cox, Ben [1 ]
Carrique, Lauren [1 ]
Di Maira, Tommaso [1 ,2 ,3 ,4 ]
Sales, Isabel [1 ]
Don, Caitlin [5 ]
Gomez-Aldana, A. [1 ]
Koshy, Dilip [5 ]
Abbey, Susan [5 ]
Lilly, Les [1 ]
Tsien, Cynthia [1 ]
Bhat, Mamatha [1 ,6 ]
Jaeckel, Elmar [1 ]
Lynch, Marie-Josee [1 ,5 ]
Selzner, Nazia [1 ,7 ]
机构
[1] Univ Toronto, Univ Hlth Network, Ajmera Transplant Ctr, Toronto, ON, Canada
[2] Hosp Univ La Fe, Liver Transplantat & Hepatol Unit, Valencia, Spain
[3] Inst Salud Carlos III, CIBERehd, Madrid, Spain
[4] IIS La Fe, Valencia, Spain
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Toronto Gen Hosp, Ajmera Transplant Ctr, Toronto, ON M5M2P3, Canada
关键词
D O I
10.1097/LVT.0000000000000274
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Since 2018, our program has utilized specific psychosocial criteria and a multidisciplinary approach to assess patients for liver transplant due to alcohol-associated liver disease (ALD), rather than the 6-month abstinence rule alone. If declined based on these criteria, specific recommendations are provided to patients and their providers regarding goals for re-referral to increase the potential for future transplant candidacy. Recommendations include engagement in treatment for alcohol use disorder, serial negative biomarker testing, and maintenance of abstinence from alcohol. In our current study, we evaluate the outcomes of patients with ALD, who were initially declined upon assessment and re-referred to our program. This is a retrospective cohort study that includes 98 patients with ALD, who were previously declined for liver transplantation and were subsequently re-referred for liver transplant assessment between May 1, 2018, and December 31, 2021. We assess the outcomes of patients who were re-referred including acceptance for transplantation following a second assessment. Of the 98 patients who were re-referred, 46 (46.9%) fulfilled the recommendations made and proceeded to further medical evaluation. Nine were eventually transplanted; others are listed and are waiting for transplant. The presence of a partner was independently associated with a higher rate of acceptance (OR 0.16, 95% CI: 0.03-0.97, p = 0.05). Most of the patients who did not proceed further (n = 52) were declined again due to ALD contraindications (n = 33, 63.4%), including ongoing drinking and lack of engagement in recommended addiction treatment. Others had medical contraindications (11.2%), clinically improved (6.1%), had adherence issues (5.1%), or lack of adequate support (2%). Patients with ALD previously declined for a liver transplant can be re-referred and successfully accepted for transplantation by fulfilling the recommendations made by the multidisciplinary team. Important factors including ongoing abstinence, engagement in addiction treatment, and social support are key for successful acceptance.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 50 条
  • [21] Alcohol-associated liver disease
    Mackowiak, Bryan
    Fu, Yaojie
    Maccioni, Luca
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [22] Black patients and women have reduced access to liver transplantation for alcohol-associated liver disease
    Kaplan, Alyson
    Wahid, Nabeel
    Fortune, Brett E.
    Verna, Elizabeth
    Halazun, Karim
    Samstein, Benjamin
    Brown, Robert S.
    Rosenblatt, Russell
    LIVER TRANSPLANTATION, 2023, 29 (03) : 259 - 267
  • [23] Liver Transplant for Alcohol-Associated Liver Disease
    Zhang, Bo-Han
    Cai, Yun-Shi
    Yang, Jia-Yin
    JAMA SURGERY, 2022, 157 (04) : 360 - 360
  • [24] Liver transplantation for alcohol-associated hepatitis
    Durkin, Claire
    Bittermann, Therese
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2023, 28 (02) : 85 - 94
  • [25] Early Liver Transplantation: An Evolving Therapeutic Option for Alcohol-Associated Liver Disease
    Elfeki, Mohamed A.
    Singal, Ashwani K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (01) : 3 - 5
  • [26] Liver Transplantation in Alcohol-Associated Liver Disease: Current Status and Future Landscape
    Louvet, Alexandre
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 809 - 817
  • [27] Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression
    Osna, Natalia A.
    Tikhanovich, Irina
    Ortega-Ribera, Marti
    Mueller, Sebastian
    Zheng, Chaowen
    Mueller, Johannes
    Li, Siyuan
    Sakane, Sadatsugu
    Weber, Raquel Carvalho Gontijo
    Kim, Hyun Young
    Lee, Wonseok
    Ganguly, Souradipta
    Kimura, Yusuke
    Liu, Xiao
    Dhar, Debanjan
    Diggle, Karin
    Brenner, David A.
    Kisseleva, Tatiana
    Attal, Neha
    Mckillop, Iain H.
    Chokshi, Shilpa
    Mahato, Ram
    Rasineni, Karuna
    Szabo, Gyongyi
    Kharbanda, Kusum K.
    BIOMOLECULES, 2024, 14 (04)
  • [28] GRAFT REJECTION IS ASSOCIATED WITH ALCOHOL RELAPSE AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE: PSYCHOSOCIAL OR IMMUNOLOGIC FACTORS?
    Lin, Emily
    Rakoski, Mina O.
    Lee, Brian T.
    HEPATOLOGY, 2022, 76 : S939 - S940
  • [30] Reply to: "Primed for the spotlight: Transplantation for alcohol-associated liver disease"
    Luther, Jay
    Dienstag, Jules L.
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 255 - 255